FDA Approves Safer Drug for Alzheimer's Agitation

Millions of Alzheimer's patients who experience severe agitation now have a safer treatment option after the FDA approved Auvelity, a drug that works differently than risky antipsychotic medications.

The approval gives hope to families struggling with one of the disease's most challenging symptoms.